Related Experiment Video
Updated: Aug 5, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor (LATS) Biosensor
Published on: September 13, 2018
The Multifaceted Roles of the Hippo-Yes-Associated Protein (YAP)/Transcriptional Coactivator with a PDZ-Binding Motif
Zihao Sui1, Ting Wang1, Chunling Yi2
1Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, D.C. 20057, USA.
Abstract:
The Hippo-Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) pathway is frequently dysregulated in cancers. Beyond tumor cell-intrinsic functions of this pathway, Hippo-YAP/TAZ signaling exerts profound influences on the tumor microenvironment (TME). In this work, we discuss recent advances in understanding how this pathway modulates the immune landscape, cancer-associated fibroblasts (CAFs), and tumor vasculature. We first examine its roles in shaping tumor immunity through regulation of the expression of cytokines, chemokines, and immune checkpoint molecules by tumor cells. We then outline how YAP/TAZ drives fibroblast activation, matrix stiffening, and promotes cancer-associated fibrosis. Finally, we highlight its reciprocal regulation with vascular endothelial growth factor (VEGF) and other proangiogenic factors that control endothelial proliferation and vessel remodeling. Together, these findings position the Hippo-YAP/TAZ axis as a key orchestrator of the immune, stromal, and vascular components of the tumor niche and a promising target for therapeutic intervention.
Insights
The Hippo-Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) pathway significantly impacts the tumor microenvironment. This pathway orchestrates immune cells, fibroblasts, and vasculature, offering a potential therapeutic target in cancer.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- The Hippo-Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) pathway is frequently dysregulated in various cancers.
- This pathway's influence extends beyond tumor cells to modulate the tumor microenvironment (TME).
Purpose of the Study:
- To review recent advances in understanding how the Hippo-YAP/TAZ pathway influences the TME.
- To explore its roles in shaping tumor immunity, cancer-associated fibroblasts (CAFs), and tumor vasculature.
Main Methods:
- Literature review of recent studies on Hippo-YAP/TAZ signaling in cancer.
- Analysis of pathway's regulation of cytokines, chemokines, immune checkpoints, fibroblast activation, and angiogenesis.
Main Results:
- Hippo-YAP/TAZ signaling regulates immune cell infiltration and function by controlling cytokine and chemokine expression.
- YAP/TAZ drives fibroblast activation, leading to matrix stiffening and promoting cancer-associated fibrosis.
- The pathway exhibits reciprocal regulation with vascular endothelial growth factor (VEGF), influencing tumor angiogenesis.
Conclusions:
- The Hippo-YAP/TAZ axis is a critical regulator of the immune, stromal, and vascular components of the TME.
- Targeting the Hippo-YAP/TAZ pathway presents a promising therapeutic strategy for cancer treatment.
More Related Videos
11:32Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
Published on: March 27, 2020
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 19, 2019
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Hedgehog Signaling Pathway
Hedgehog Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway